Our study underscores the critical need to identify specific substrates and molecular mechanisms of UFM1 in cell culture and animal models, to identify risks and benefits of manipulating the UFM1 pathway as potential therapeutic avenue for AD. Here, UFM1 is linked to Alzheimer disease.